YD Bio Limited Ordinary Shares
NASDAQ: YDES0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ethan Shen
- Employees
- 4
- Headquarters
- Taipei, Taiwan
- IPO year
- 2025
- Market cap
- $186.3M
- Website
- https://www.ydesgroup.com
Loading YDES…
Loading profile data…Frequently asked questions about YDES
What does YD Bio Limited Ordinary Shares (YDES) do?
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Where does YDES trade?
YD Bio Limited Ordinary Shares (YDES) trades on the NASDAQ Global Select.
What sector is YDES in?
YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of YD Bio Limited Ordinary Shares?
Ethan Shen is the chief executive officer of YD Bio Limited Ordinary Shares (YDES).
Where is YD Bio Limited Ordinary Shares headquartered?
YD Bio Limited Ordinary Shares is headquartered in Taiwan.
Does YDES pay a dividend?
YD Bio Limited Ordinary Shares (YDES) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did YDES go public?
YD Bio Limited Ordinary Shares (YDES) completed its initial public offering in 2025.